Advanced Multiple Sclerosis (1)

Progressive Multiple Sclerosis (1)

Recruiting (1)

phase 2/phase 3 (1)

Queen Mary University of London (1)

Barts & The London NHS Trust (1)

Merck Serono Limited, UK (1)

Multiple Sclerosis Society of Great Britain & Northern Ireland (1)

National Institute for Health Research, United Kingdom (1)

National Multiple Sclerosis Society USA (1)

cladribine (mavenclad®) (1)

placebo (1)

drug (1)

Other (1)

Interventional (1)

advanced multiple sclerosis

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jun 9, 2022